Pharmaceutical Executive December 11, 2025
Key Takeaways
- DTC prescription drug models are reshaping the pharma industry by altering pricing dynamics and enhancing patient access, driven by policy support and patient demand.
- Data security and compliance are critical as DTC initiatives gain traction, requiring collaboration between legal, compliance, and technology teams.
- Integration of telehealth, pharmacy, and fulfillment is creating a seamless patient experience, supported by automation and generative AI.
- The shift to DTC models is seen as a fundamental change, offering transparency, convenience, and personalization in the evolving pharmaceutical landscape.
Why the new wave of direct-to-consumer access represents more than a passing trend.
Once viewed as an experimental approach reserved for niche therapies, direct-to-consumer (DTC) prescription drug models are starting to become a...







